Related Experiment Video
Updated: May 13, 2026

04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
High-risk behaviour in hypomanic states.
Kathryn Fletcher1, Gordon Parker, Amelia Paterson
1School of Psychiatry, University of New South Wales, NSW, Australia. k.fletcher@unsw.edu.au
Journal of Affective Disorders
|March 16, 2013
Summary
Risk-taking behaviors during hypomania are common in bipolar II disorder and lead to serious consequences like financial strain and interpersonal conflict. Many patients are ambivalent about treating hypomania due to its perceived benefits, despite these risks.
Area of Science:
- Psychiatry
- Clinical Psychology
- Neuroscience
Background:
- Risk-taking behaviors during hypomanic states are recognized but not fully detailed in research.
- The potential for harm to individuals and others associated with these behaviors requires further investigation.
- Bipolar II disorder is characterized by hypomanic episodes, which can involve significant risk-taking.
Purpose of the Study:
- To examine the nature of risk-taking behaviors during hypomanic states in individuals with bipolar II disorder.
- To identify the consequences of these risk-taking behaviors, including potential impairment.
- To understand patient perspectives on treating hypomania in light of associated risks.
Main Methods:
- Recruitment of 93 participants diagnosed with bipolar II disorder from a Sydney-based clinic.
- Diagnostic confirmation based on clinician judgment and DSM-IV criteria.
- Assessment of past risk-taking behaviors during hypomanic episodes using detailed questionnaires.
Main Results:
- Common risk-taking behaviors included excessive spending, substance use, dangerous driving, and risky sexual activities.
- Significant consequences reported were interpersonal conflict, financial burdens, guilt, shame, and remorse.
- Less than 20% of participants believed hypomania should be treated due to its associated risks.
Conclusions:
- Risk-taking behaviors during hypomania are prevalent and associated with severe consequences.
- Patient ambivalence towards treating hypomania, often romanticized, complicates clinical management.
- Identifying high-risk behaviors is crucial for developing effective wellbeing plans for individuals with bipolar II disorder.
Related Concept Videos
Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Borderline Personality Disorder
Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...
Genetic and Environmental Contributions
Borderline Personality...
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
